Zhang Yiming’s AI drug discovery spin-off hits $1.5 billion valuation
Anew Labs has raised $290 million in its first independent funding round, underscoring investor enthusiasm for…
From designing molecules to making medicines: AI drug discovery enters its next phase
AI is moving from lab novelty to clinical reality. The next test is whether faster molecule…
Early Shanghai trial data points to promise for therapeutic mRNA cancer vaccines
By Da Cheung The American Society of Clinical Oncology (ASCO) annual meeting, which concluded on June…
Latest
- Zhang Yiming’s AI drug discovery spin-off hits $1.5 billion valuation
- Mecka AI raises $60 million as Sequoia and Nvidia bet on robot training data
- Doubao’s AI phone rejected by major platforms
- Infinigence secures 2.3 billion yuan in fresh funds
- After forced Meta split, AI startup Manus regroups with new $500 million funding
